Skip to content
Screener

Price / sales at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.3×
Corcept Therapeutics logo
Corcept TherapeuticsCORT
11.2×-0.1×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×
XER
Xeris Biopharma Holdings, Inc.XERS
4.1×+1.0×
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
1,373.5×+1,373×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
7.7×+0.5×

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$8.9B+233%
Enterprise value$8.84B+231%

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001658247-26-000040

FAQ

What is Crinetics Pharmaceuticals's price / sales?
Crinetics Pharmaceuticals (CRNX) reported price / sales of 210.5× in Q1 2026.
How has Crinetics Pharmaceuticals's price / sales changed year-over-year?
Crinetics Pharmaceuticals's price / sales decreased by 94.9% year-over-year, from 4,106.4× to 210.5×.
What is the long-term trend for Crinetics Pharmaceuticals's price / sales?
Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's price / sales has grown at a -17.7% compound annual growth rate (CAGR), from 1,251.8× to 574×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Crinetics Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude